Admission Date:  [**2140-1-22**]     Discharge Date:  [**2140-1-29**]   Service:  Urology  CHIEF COMPLAINT:  Status post left radical nephrectomy and splenectomy for renal cell carcinoma.
Status post open surgical removal of a left renal stone over 40 years ago.
Atenolol 50 mg p.o.
Hydrochlorothiazide 25 mg p.o.
Multivitamin one tablet p.o.
[**Hospital 1749**] HOSPITAL COURSE:  On [**2140-1-22**], the patient went to the operating room and underwent a left radical nephrectomy.
At that point, General Surgery was consulted, and the patient underwent a splenectomy on top of his left radical nephrectomy.
The patient received 3 units of packed red blood cells in the operating room.
An nasogastric tube was left in place to decompress the stomach, and he was also on an epidural.
The patient did require some intravenous Haldol with a good response, and the Dilaudid was removed the patient's epidural as narcotics were minimized.
Also of note, the patient had some expiratory wheezing and some low oxygen saturations at times and received some albuterol nebulizers with a good response.
It was noted around postoperative day four that the hematocrit was slowly trending down, so the patient was transfused 2 units of packed red blood cells with a good response.
The Foley catheter had been discontinued, and the patient was urinating on his own.
Of note, the patient was given his remaining two vaccines because he had previously received a pneumovax vaccine.
He received the H-flu and the meningococcus vaccine.
His staples were also removed prior to discharge on postoperative day seven.
CONDITION AT DISCHARGE:   The patient's was stable; tolerating a regular diet, tolerating Tylenol for pain, ambulating, and having normal bowel movements.
DISCHARGE STATUS:  Discharge status was to home with [**Hospital6 3429**] for home physical therapy evaluation.
Status post left radical nephrectomy and splenectomy secondary to renal cell carcinoma.
Atenolol 50 mg p.o.
Hydrochlorothiazide 25 mg p.o.
Multivitamin one tablet p.o.
Tylenol 325 mg to 650 mg p.o.
